Rapamycin's Risks Limit Its Prescription
P
Peter Attia MD discusses hesitancy in prescribing rapamycin.
Story of claim
Due to uncertain long-term effects, rapamycin is not widely prescribed, with less than 10% of patients receiving it.
- Goal: Explain the risks and uncertainties of prescribing rapamycin.
- Proof: Short-term effects are non-harmful, but long-term efficacy and safety remain unproven.
- Nuances:
- Less than 10% of patients are on rapamycin.
- Physicians giving it like Tic Tacs.
- Short-term effects seem non-harmful.
- Taken by the speaker for over 6 years.
- Impact on Life: Potential for longevity is overshadowed by risk concerns, affecting prescription rates.
Investments
- Price:
- Time:
- Effort: Significant understanding of the risks involved.
Risks
Unknown long-term effects; ethical prescribing concerns.
Get Started 🚀
- Discuss with a healthcare provider about potential risks.
- Consider alternative longevity strategies.
Brogevity AI can make mistakes. Check important info.